Brinker Capital Investments’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $776K | Buy |
321,879
+82,522
| +34% | +$199K | 0.01% | 1326 |
|
|
2025
Q1 | $529K | Buy |
239,357
+142,665
| +148% | +$315K | 0.01% | 1398 |
|
|
2024
Q4 | $527K | Sell |
96,692
-39,057
| -29% | -$213K | 0.01% | 1332 |
|
|
2024
Q3 | $1.13M | Buy |
135,749
+6,177
| +5% | +$51.3K | 0.01% | 990 |
|
|
2024
Q2 | $928K | Buy |
129,572
+14,333
| +12% | +$103K | 0.01% | 1026 |
|
|
2024
Q1 | $999K | Buy |
115,239
+14,519
| +14% | +$126K | 0.01% | 983 |
|
|
2023
Q4 | $692K | Buy |
100,720
+35,564
| +55% | +$244K | 0.01% | 1091 |
|
|
2023
Q3 | $652K | Buy |
65,156
+11,564
| +22% | +$116K | 0.01% | 1101 |
|
|
2023
Q2 | $666K | Buy |
53,592
+22,833
| +74% | +$284K | 0.01% | 1104 |
|
|
2023
Q1 | $431K | Buy |
30,759
+15,690
| +104% | +$220K | 0.01% | 1190 |
|
|
2022
Q4 | $216K | Buy |
+15,069
| New | +$216K | ﹤0.01% | 1273 |
|
|
2022
Q3 | – | Sell |
-15,520
| Closed | -$441K | – | 1373 |
|
|
2022
Q2 | $441K | Buy |
+15,520
| New | +$441K | 0.01% | 1023 |
|